Shareholders to Vote on Massive Stock Authorization Increase and New Equity Plan

summarizeSummary

Bed Bath & Beyond filed its definitive proxy statement, seeking shareholder approval to increase authorized common stock by 100 million shares and to expand its equity incentive plan, which includes substantial contingent awards for its CEO.

check_boxKey Events

• Proposed Increase in Authorized Common Stock

  Shareholders will vote on an amendment to increase the authorized common stock from 100,000,000 to 200,000,000 shares. As of March 10, 2026, there were 69,334,797 shares outstanding. If all authorized shares were issued, dilution would be approximately 188%.

• Amendment to Equity Incentive Plan

  The company seeks approval to amend its 2005 Equity Incentive Plan, adding 4,291,000 newly authorized shares. This would increase the fully-diluted overhang from 5.4% to approximately 10.6%.

• Significant CEO Equity Awards Contingent on Approval

  As part of the amended equity plan, CEO Marcus Lemonis was granted contingent awards on March 11, 2026, totaling 1,500,000 Restricted Stock Units (RSUs) and 600,000 performance shares (at target), subject to shareholder approval of the Restated Plan.

• Annual Meeting Proposals

  Other proposals for the May 14, 2026, Annual Meeting include the election of seven directors, ratification of KPMG LLP as the independent auditor, and an advisory vote on named executive officer compensation.

auto_awesomeAnalysis

Bed Bath & Beyond has filed its definitive proxy statement, outlining critical proposals for its upcoming annual meeting. The most significant proposals include a request to double the authorized common stock from 100 million to 200 million shares and to amend its equity incentive plan to add over 4.2 million new shares. The proposed increase in authorized shares, if fully utilized, represents a potential dilution of approximately 188% relative to current outstanding shares, which is a substantial amount. This move provides the company with significant flexibility for future capital-raising activities, acquisitions, or other strategic transactions, which could be vital for its long-term stability and growth, especially given its recent financial improvements. However, it also poses a considerable risk of dilution for existing shareholders. The amendment to the equity incentive plan, which includes significant contingent awards for CEO Marcus Lemonis, is aimed at attracting and retaining key talent, but further contributes to potential dilution.